Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20
BW Businessworld

Cipla Launches RT-PCR Test Kit 'Viragen' In India Partnership With Ubio Biotech

Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems

Photo Credit :

1611752815_EEhdYW_cipla.jpg

Drug major Cipla on Thursday announced the commercialisation of its RT-PCR test kit 'ViraGen' for COVID-19 in India, in partnership with Ubio Biotechnology Systems.

'This launch will help address the current testing services and capacity issues while reaffirming the company's ongoing expansion in the diagnostic space,' Cipla said in a regulatory filing.

Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems, the company stated.

The company will commence supply of the COVID-19 virus detection kit from May 25, 2021.

Umang Vohra, MD and Global CEO, Cipla, said, “Cipla has been working relentlessly to ensure accessibility to treatments in this fight against COVID-19. Guided by our core purpose of 'Caring for Life', this partnership will enable us to reach out to more people across the country at a crucial time like now”.

ViraGen is Cipla's third offering in the COVID-19 testing segment. 

(PTI)


Tags assigned to this article:
cipla drug major COVID-19 Testing